The price-to-earnings ratio for HCA Healthcare Inc (NYSE: HCA) is 14.28x, which is above its average ratio. Moreover, the 36-month beta value for HCA is 1.64. Analysts have varying opinions on the stock, with 15 analysts rating it as a “buy,” 3 as “overweight,” 6 as “hold,” and 1 as “sell.”
The public float for HCA is 181.00M and currently, short sellers hold a 2.43% of that float. On January 22, 2025, HCA’s average trading volume was 1.49M shares.
HCA) stock’s latest price update
HCA Healthcare Inc (NYSE: HCA)’s stock price has dropped by -0.08 in relation to previous closing price of 318.47. Nevertheless, the company has seen a gain of 4.06% in its stock price over the last five trading days. zacks.com reported 2025-01-20 that HCA’s fourth-quarter results are expected to benefit from rising admissions and patient days. However, increasing expenses are a concern.
HCA’s Market Performance
HCA’s stock has risen by 4.06% in the past week, with a monthly rise of 6.37% and a quarterly drop of -23.43%. The volatility ratio for the week is 2.10% while the volatility levels for the last 30 days are 2.32% for HCA Healthcare Inc. The simple moving average for the past 20 days is 4.22% for HCA’s stock, with a -7.69% simple moving average for the past 200 days.
Analysts’ Opinion of HCA
Many brokerage firms have already submitted their reports for HCA stocks, with JP Morgan repeating the rating for HCA by listing it as a “Neutral.” The predicted price for HCA in the upcoming period, according to JP Morgan is $380 based on the research report published on December 17, 2024 of the previous year 2024.
Wells Fargo, on the other hand, stated in their research note that they expect to see HCA reach a price target of $320, previously predicting the price at $400. The rating they have provided for HCA stocks is “Underweight” according to the report published on November 25th, 2024.
HCA Trading at -0.19% from the 50-Day Moving Average
After a stumble in the market that brought HCA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.72% of loss for the given period.
Volatility was left at 2.32%, however, over the last 30 days, the volatility rate increased by 2.10%, as shares surge +6.95% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.76% lower at present.
During the last 5 trading sessions, HCA rose by +4.06%, which changed the moving average for the period of 200-days by -2.14% in comparison to the 20-day moving average, which settled at $305.30. In addition, HCA Healthcare Inc saw 6.01% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HCA starting from Whalen Kathleen M, who sale 1,474 shares at the price of $357.99 back on Nov 14 ’24. After this action, Whalen Kathleen M now owns 9,454 shares of HCA Healthcare Inc, valued at $527,677 using the latest closing price.
Billington Phillip G, the SVP-Internal Audit Services of HCA Healthcare Inc, sale 3,897 shares at $350.00 during a trade that took place back on Nov 14 ’24, which means that Billington Phillip G is holding 52,702 shares at $1,363,950 based on the most recent closing price.
Stock Fundamentals for HCA
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.5 for the gross margin
The net margin for HCA Healthcare Inc stands at 0.09. The total capital return value is set at 0.24.
Based on HCA Healthcare Inc (HCA), the company’s capital structure generated 1.05 points at debt to capital in total, while cash flow to debt ratio is standing at 0.24. The debt to equity ratio resting at -20.57. The interest coverage ratio of the stock is 5.19.
Currently, EBITDA for the company is 12.72 billion with net debt to EBITDA at 3.01. When we switch over and look at the enterprise to sales, we see a ratio of 1.76. The receivables turnover for the company is 7.02for trailing twelve months and the total asset turnover is 1.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.12.
Conclusion
To wrap up, the performance of HCA Healthcare Inc (HCA) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
